Please Wait.....
Report
United States Autoinjector Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 250 Pages I EMR Inc.
The United States autoinjector market was valued at USD 0.65 Billion in 2024, driven by the regulatory support and technological advancements in the region. The market is anticipated to grow at a CAGR of 14.20% during the forecast period of 2025-2034, with the values likely to reach USD 2.45 Billion by 2034. The market is driven by growing demand for self-administered therapies, advancements in smart autoinjectors, and increased adoption in home healthcare due to rising chronic disease prevalence.
United States Autoinjector Market Overview
Autoinjector devices are prefilled, self-administering drug delivery systems designed for rapid, accurate, and convenient injection without professional assistance. The market for autoinjectors in the United States is experiencing significant growth, driven by rising chronic disease prevalence, increasing self-medication trends, and technological advancements enhancing patient compliance and safety.
United States Autoinjector Market Growth Drivers
Next-Generation Testing Technology Set to Augment Market Demand
Integrating advanced testing systems will enhance the reliability and quality assurance of autoinjector devices. For instance, in June 2024, Instron launched its next-generation autoinjector testing system, enabling comprehensive functionality testing on a single platform. By streamlining validation and production transfer processes, this innovation supports efficiency and product safety, ultimately accelerating market growth.
United States Autoinjector Market Trends
Some of the notable trends in the market include expanding regulatory approvals for injectable therapies and increasing government initiatives focused on emergency preparedness and access to critical self-injection treatments.
Regulatory Advancements is Poised to Accelerate Market Growth
Expanding regulatory approvals for treatments represent a significant trend in the autoinjector devices market. In August 2024, the U.S. FDA approved Zurnai, the first nalmefene hydrochloride auto-injector for emergency opioid overdose treatment. This milestone, in alignment with the FDA's overdose prevention framework, is anticipated to foster innovation and accelerate market growth.
Rising Government Initiatives in Emergency Preparedness is Likely to Elevate United States Autoinjector Market Value
A growing trend in the market is the increased investment in emergency preparedness and public health response. In April 2025, Barda's funding to Kaleo for developing 2-PAM autoinjectors highlighted the government's commitment to enhancing rapid-response capabilities. Such initiatives are expected to drive market growth by advancing autoinjector innovation and expanding strategic stockpiles.
United States Autoinjector Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Disposable
- Reusable
??- Empty
??- Prefilled
Market Breakup by Volume
- Up to 3ml
- Above 3ml
Market Breakup by Technology
- Automatic
- Manual
Market Breakup by Route of Administration
- Subcutaneous
- Intramuscular
Market Breakup by Application
- Autoimmune Disorders
- Rheumatoid Arthritis
- Diabetes
- Multiple Sclerosis
- Anaphylaxis
- Others
Market Breakup by End User
- Hospitals & Clinics
- Homecare Settings
- Ambulatory Surgical Centers
- Others
United States Autoinjector Market Share
Segmentation Based on Application to Witness Substantial Growth
Based on the type, the market is segmented into disposable and reusable. The disposable segment is anticipated to have a substantial share of the market, driven by increasing demand for hygienic and single-use medical products across healthcare settings. Enhanced infection control protocols, cost-effectiveness in bulk procurement, and minimal maintenance requirements contribute to its widespread adoption. Additionally, the growing preference in outpatient and homecare environments further strengthens the segment's projected market dominance.
United States Autoinjector Market Analysis by Region
The autoinjector devices market in the United States demonstrates strong regional performance, with leading growth observed in the Mideast and Southeast regions. These areas benefit from advanced healthcare infrastructure, high chronic disease prevalence, and increasing patient awareness. Additionally, the Southwest regions contribute significantly, driven by rising demand for self-administration solutions and supportive healthcare policies.
Leading Players in the United States Autoinjector Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Eli Lilly and Company
Eli Lilly and Company, founded in 1876 and headquartered in Indianapolis, Indiana, plays a pivotal role in the market. In August 2024, the company expanded access to Zepbound (tirzepatide) by introducing single-dose vials and autoinjector pens for adults with obesity. This launch enhances treatment accessibility and supports patients with self-administered, subcutaneous weight management solutions.Teva Pharmaceuticals: Teva Pharmaceuticals plays a significant role in the autoinjector market. It was established in 1901 and is headquartered in Tel Aviv, Israel. The company offers Epinephrine injection, USP (auto-injector), a generic equivalent to EpiPen and EpiPen Jr. These pre-filled, single-dose autoinjectors are used in the emergency treatment of allergic reactions, highlighting Teva's commitment to accessible, life-saving therapies.
Ypsomed
Ypsomed, headquartered in Burgdorf, Switzerland, was established in 1984 and is actively contributing to the autoinjector devices market. The company's innovative product, YpsoMate On, is a pre-filled autoinjector featuring integrated connectivity that logs injections automatically and enhances therapy adherence. Recognized with the Pharmapack 2022 Innovation Award, it supports digital therapy management with a sustainable, user-friendly design.
SHL Medical
SHL Medical, established in 1989, is headquartered in Switzerland. The company specializes in the development, manufacturing, and assembly of drug delivery devices, including autoinjectors. In 2022, SHL Medical expanded into the U.S. market with a new facility in North Charleston, South Carolina. Their product lineup includes the Molly autoinjectors, designed for self-injection systems, crucial for treating chronic diseases. This move enhances their ability to meet growing demand in the U.S. autoinjector devices market.
Other key players in the market include Pfizer, Inc., Amgen, Sanofi, Mylan N.V., and Biogen.
Key Questions Answered in the United States Autoinjector Market Report
- What was the United States autoinjector market value in 2024?
- What is the United States autoinjector market forecast outlook for 2025-2034?
- What is the market segmentation based on type?
- What is the market segmentation based on volume?
- What is the market segmentation based on technology?
- What is the market breakup based on the route of administration?
- How is the market segmented based on application?
- How is the market divided based on the end user?
- What are the major factors aiding the United States autoinjector market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major United States autoinjector market trends?
- Which type is expected to dominate the market segment?
- Which volume is expected to dominate the market segment?
- Which technology is expected to dominate the market segment?
- Which route of administration is projected to lead the market segment?
- Which application is anticipated to drive the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players involved in the United States autoinjector market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 United States Autoinjector Market Overview
3.1 North America Autoinjector Market
3.1.1 North America Autoinjector Market Historical Value (2018-2024)
3.1.2 North America Autoinjector Market Forecast Value (2025-2034)
3.2 United States Autoinjector Market
3.2.1 United States Autoinjector Market Historical Value (2018-2024)
3.2.2 United States Autoinjector Market Forecast Value (2025-2034)
4 United States Autoinjector Market Landscape*
4.1 United States Autoinjector Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 United States Autoinjector Market: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Volume
4.2.3 Analysis by Technology
4.2.4 Analysis by Route of Administration
4.2.5 Analysis by Application
5 United States Autoinjector Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter's Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 United States Autoinjector Market Segmentation (218-2034)
6.1 United States Autoinjector Market (2018-2034) by Type
6.1.1 Market Overview
6.1.2 Disposable
6.1.3 Reusable
6.1.3.1 Empty
6.1.3.2 Prefilled
6.2 United States Autoinjector Market (2018-2034) by Volume
6.2.1 Market Overview
6.2.2 Up to 3ml
6.2.3 Above 3ml
6.3 United States Autoinjector Market (2018-2034) by Technology
6.3.1 Market Overview
6.3.2 Automatic
6.3.3 Manual
6.4 United States Autoinjector Market (2018-2034) by Route of Administration
6.4.1 Market Overview
6.4.2 Subcutaneous
6.4.3 Intramuscular
6.5 United States Autoinjector Market (2018-2034) by Application
6.5.1 Market Overview
6.5.2 Autoimmune Disorders
6.5.3 Rheumatoid Arthritis
6.5.4 Diabetes
6.5.5 Multiple Sclerosis
6.5.6 Anaphylaxis
6.5.7 Others
6.6 United States Autoinjector Market (2018-2034) by End User
6.6.1 Market Overview
6.6.2 Hospitals & Clinics
6.6.3 Homecare Settings
6.6.4 Ambulatory Surgical Centers
6.6.5 Others
7 Regulatory Framework
8 Patent Analysis
8.1 Analysis By Phase of Patent
8.2 Analysis by Publication Year
8.3 Analysis by Issuing Authority
8.4 Analysis by Patent Age
8.5 Analysis by CPC Analysis
8.6 Analysis by Patent Valuation
9 Funding and Investment Analysis
9.1 Analysis by Funding Instances
9.2 Analysis by Type of Funding
9.3 Analysis by Funding Amount
9.4 Analysis by Leading Players
9.5 Analysis by Leading Investors
9.6 Analysis by Geography
10 Strategic Initiatives
10.1 Analysis by Partnership Instances
10.2 Analysis by Type of Partnership
10.3 Analysis by Leading Players
10.4 Analysis by Geography
11 Supplier Landscape
11.1 Market Share Analysis (Top 5 Companies)
11.2 Eli Lilly and Company
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Company News and Development
11.2.5 Certifications
11.3 Pfizer, Inc.
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Company News and Development
11.3.5 Certifications
11.4 Teva Pharmaceuticals
11.4.1 Financial Analysis
11.4.2 Product Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Company News and Development
11.4.5 Certifications
11.5 Amgen
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Company News and Development
11.5.5 Certifications
11.6 Sanofi
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Company News and Development
11.6.5 Certifications
11.7 Mylan N.V.
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Company News and Development
11.7.5 Certifications
11.8 Ypsomed
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Company News and Development
11.8.5 Certifications
11.9 SHL Behring AG
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Company News and Development
11.9.5 Certifications
11.10 Biogen
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Company News and Development
11.10.5 Certifications
12 United States Autoinjector Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security